IncellDx, Inc. Announces Successful Presentation of Its Personalized HIV Monitoring Assays at the 5th Santorini Conference in Greece
10/6/2010 9:42:21 AM
MENLO PARK, Calif.--(BUSINESS WIRE)--IncellDx, Inc. announces the presentation of multicenter data by Dr. George Lallas of FlowCytoGen Laboratories at the '5th Santorini Conference on Functional Genomics towards a Personalized Health Care.' Dr. Lallas’ talk described how the combination of the HIV Reservoirs Assay and the HIV Tropism Assay are effective in the determination of efficacy for HIV therapy in individual patients. These assays can be used on individuals over time to monitor and adjust the therapeutic regimen.